NCT02391909View on ClinicalTrials.gov

Phase 4 Study To Assess The Safety Of Vivotif At Different Release Titers Among Travelers

CompletedOBSERVATIONAL

Enrollment

855

Participants

Timeline

Start Date

August 26, 2015

Primary Completion Date

October 6, 2016

Study Completion Date

February 21, 2017

Conditions

Typhoid Fever

Interventions

BIOLOGICAL

Vivotif

Trial Locations (1)

21230

Passport Health, Baltimore

Sponsors

Lead Sponsor

Bavarian Nordic

Collaborators (1)

Emergent BioSolutions

All Listed Sponsors

collaborator

Emergent BioSolutions

INDUSTRY

lead

Bavarian Nordic

INDUSTRY